What is the Buying Price of Nephrocare Health Services Share?

The Buying Price of Nephrocare Health Services share is 636.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Nephrocare Health Services Share at Choice?

To buy Nephrocare Health Services stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Nephrocare Health Services, choose your preferred order type, and place the trade.

What is the PE ratio of Nephrocare Health Services Shares?

The Price-to-earnings (P/E) ratio of Nephrocare Health Services shares is 77.93. You can compare it with the sector average for relative valuation.

What is the PB ratio of Nephrocare Health Services Shares?

The Price to Book (P/B) ratio Nephrocare Health Services shares is 5.36. Useful to assess the stock's value relative to its book value.

Is Nephrocare Health Services Overvalued?

To assess Nephrocare Health Services’s valuation compare Sector P/E, P/B which are 55.46 & -15.45 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Nephrocare Health Services?

The Market Cap of Nephrocare Health Services is 6387.69 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Nephrocare Health Services Share Price?

The 52 week high and low prices of Nephrocare Health Services share price is 663.9 & 446. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Nephrocare Health Services belong to?

Nephrocare Health Services belongs to the Healthcare sector.

Nephrocare Health Services Share price

NEPHROPLUS

Healthcare Mid Cap

636.6

37.90 (6.33%)

NSE

BSE

Last updated on 1 Jun, 2026 | 15:57 IST

BUYSELL

Today's High

650.00

Today's Low

598.70

52 Week Low

446.00

52 Week High

663.90

Free Demat with Zero AMC*

Nephrocare Health Services Chart

ChartIQ

TradingView

Nephrocare Health Services Share Key Metrics

Volume

5.06 L

Market Cap

6387.69 CR

LTQ@LTP

38@636.60

ATP

636.12 Var Margin

15.24 %

Circuit Range

479-718.4

Delivery %

62.1 %

Value

32.20 CR

ASM/GSM

No

Market Lot

1

Summary

1 Jun, 2026 | 15:57 को, Nephrocare Health Services का शेयर प्राइस आज ₹636.6 पर है, जो दिन के लिए 37.90% की 6.33 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹598.70 और ₹650.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹446.00 से ₹663.90 तक रही है। ट्रेडिंग गतिविधि के मामले में, Nephrocare Health Services ने 506215 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹100340717 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹63612 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 38,63660 रही। यह स्टॉक ₹479-718.4 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹32.20 CR है। दिन के लिए डिलीवरी परसेंटेज 62.1% रही। इसके अतिरिक्त, Nephrocare Health Services वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Nephrocare Health Services Fundamentals

P/E Ratio

77.93

P/B Ratio

5.36

Div. Yield

0

Sector P/E

55.46

Sector P/B

-15.45

Sec. Div. Yield

0.19

Nephrocare Health Services Resistance and Support

Pivot 603.42

Resistance

First Resistance

610.84

Second Resistance

622.97

Third Resistance

630.39

Support

First Support

591.29

Second Support

583.87

Third Support

571.74

Nephrocare Health Services Shareholding Pattern

2026-27
2025-26

Total Promoters

Segment

Percent

Total Promoters

63.85%

Mutual Fund

3.44%

Insurance

1.05%

Foreign Institutional Investors

3.59%

Domestic Institutional Investors

4.19%

Retail

23.88%

Others

0%

Total Promoters

SEP '25

0%

DEC '25

63.85%

Nephrocare Health Services Corporate Actions

Date	Agenda
2026-05-19	Audited Results
2026-02-10	Quarterly Results

Nephrocare Health Services News

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Nephrocare Health Services will participate in an analyst/institutional investor meeting hosted by Bank of America on June 04, 2026. This interaction is part of the BOFA Healthcare Tour and will take place in Hyderabad. No UPSI will be discussed.

May 27 2026 16:33:25

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Acquisition

Nephrocare Health Services has incorporated NPHSK LLP, a new step-down wholly-owned subsidiary in Kazakhstan. This strategic move aims to expand the company's kidney care and dialysis services network in the region.

May 26 2026 22:14:35

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Nephrocare Health Services will participate in the HSBC Singapore Conference in Mumbai on June 18-19, 2026. The company will hold group and one-on-one meetings with investors, discussing publicly available information.

May 26 2026 20:27:43

Nephrocare Health Services Ltd - 544647 - Re-Appointment Of Internal Auditor

Nephrocare Health board convened on May 19, 2026, approving its FY26 audited standalone and consolidated financial results. The board also sanctioned a Rs.10 crore investment in its Nepal subsidiary and granted in-principal approval for Rs.140 crore in collateral support across its Singapore and Saudi Arabia subsidiaries to facilitate credit facilities.

May 19 2026 19:13:35

Nephrocare Health Services Ltd - 544647 - Issuance Of Corporate Guarantee

Nephrocare Health Services board approved collateral/security support totaling Rs. 140 crore for its Singapore and Saudi Arabia subsidiaries. This support will enable the subsidiaries to avail credit facilities from overseas banks, facilitating their business operations and working capital needs.

May 19 2026 19:07:36

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Nephrocare Health Services reported strong Q4 FY26 results with revenue up 21.2% YoY to Rs.265.6 crore and net profit increasing by 27.4% YoY to Rs.35.1 crore, driven by higher treatment volumes. Full-year FY26 revenue grew 32.2% to Rs.998.8 crore.

May 19 2026 18:44:32

Nephrocare Health Services Ltd - 544647 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 19, 2026

Nephrocare Health Services' board approved audited FY26 cons. financial results, reporting ₹9,988.45 mn revenue and ₹768.40 mn net profit. The board also approved a ₹10 cr investment in its Nepal subsidiary for operations and ₹140 cr collateral support for its Singapore and Saudi Arabia units to secure credit facilities.

May 19 2026 17:53:13

Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

The Board of Directors of Nephrocare Health Services took on record the Monitoring Agency Report for IPO proceeds utilization for the quarter ended March 31, 2026. The report highlights Rs.177.75 crore of unutilized IPO proceeds and a delay in capital expenditure for establishing new dialysis clinics.

May 14 2026 17:33:59

Nephrocare Health Services Limited

Nephrocare Health Services board will meet on May 19, 2026, to consider and approve its audited standalone and consolidated financial results for the year ended March 2026. This meeting is for the full fiscal year.

May 04 2026 14:56:01

Nephrocare Health Services Ltd - 544647 - Board Meeting Intimation for Intimation Of Board Meeting For Considering Audited Financial Results Of The Company.

Nephrocare Health's Board is scheduled to meet on May 19, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.

May 04 2026 14:54:53

Name	Position
Vikram Vuppala	Chairman & Managing Director
Vishal Vijay Gupta	Nominee Director of BVP Trust

Nephrocare Health Services Similar Stocks

Blue Jet Healthcare Ltd.

446.65

-2.70 (0.60%)

Yatharth Hospital & Trauma Care Services Ltd.

792.85

-3.65 (0.46%)

Suven Life Sciences Ltd.

274.85

-4.49 (1.61%)

Sanofi India Ltd.

3117.60

20.50 (0.66%)

FDC Ltd.

395.15

-9.85 (2.43%)

Kovai Medical Center & Hospital Ltd.

5369.50

9.00 (0.17%)

Aarti Pharmalabs Ltd.

642.35

9.10 (1.44%)

Senores Pharmaceuticals Ltd.

1067.80

-52.85 (4.72%)

Supriya Lifescience Ltd.

1052.50

83.80 (8.65%)

Innova Captab Ltd.

860.80

10.40 (1.22%)

Nephrocare Health Services FAQs

Nephrocare Health Services शेयर का खरीद मूल्य 636.6 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Nephrocare Health Services शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Nephrocare Health Services शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 77.93 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Nephrocare Health Services शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 5.36 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Nephrocare Health Services शेयर का प्राइस-टू-बुक (पी/बी) रेशियो -15.45 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Nephrocare Health Services का मार्केट कैप 6387.69 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Nephrocare Health Services शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 663.90 और 446.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।